Clinical Trial Update: The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL [Phase 2]

View source ↗

Summary

Phase 2 study evaluating elimination of total body irradiation for NGS-MRD negative children, adolescents, and young adults with B-cell acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Pediatric Transplantation & Cellular Therapy Consortium | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING